ProShares Bitcoin ETF vs 22nd Century Group Inc — how do they compare? ProShares Bitcoin ETF trades at $8.56, while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). Which is the better fit depends on your goals.
| BITO | XXII | |
|---|---|---|
Sector | Crypto-linked | Technology |
52-Week High | $22.27 | $801.00 |
52-Week Low | $7.98 | $3.72 |
Market Cap | — | $1.52M |
Enterprise Value | — | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
BITO trades at $8.55, down 1.04% with a bearish technical outlook as moving averages signal selling pressure. The ETF faces fundamental challenges with high fees impacting returns compared to spot Bitcoin ETFs, evidenced by a 24.26% decline over five years despite Bitcoin's 84.59% gain. Recent dividends of $0.01 provide minimal yield, while sentiment remains cautious amid crypto market volatility.
The outlook is bearish due to structural cost disadvantages and underperformance versus competitors. Risks include fee erosion, regulatory uncertainty, and Bitcoin price correlation breakdown. Analyst consensus rates BITO a Sell for long-term investors, highlighting its limited utility beyond tactical trading despite institutional demand for crypto exposure.
22nd Century Group (XXII) trades at $4.31, down 0.92% on the day, with a neutral technical signal and bearish moving averages. The company shows deep unprofitability with a gross margin of -52.19% and net margin of -65.76%, though revenue was $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, and news highlights retail expansion for VLN reduced-nicotine cigarettes in California and New York.
The outlook remains speculative with high execution risk amid persistent losses, but analyst sentiment is bullish with 75% buy ratings. Key risks include negative cash flow from operations, regulatory hurdles for tobacco products, and the need for successful commercialization of VLN to achieve profitability.
Trailing returns across standard periods
BITO offers exposure to Bitcoin returns primarily through Bitcoin futures contracts. It provides a regulated way for investors to trade Bitcoin performance within a traditional brokerage account without direct ownership.
Read more on BITO →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →